Published in Health Technol Assess on January 01, 1997
The role of the routine neonatal examination. BMJ (1999) 1.46
The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child (2006) 1.33
International perspectives on newborn screening. J Inherit Metab Dis (2006) 1.21
Screening for medium chain acyl-CoA dehydrogenase deficiency has still not been evaluated. . BMJ (2001) 0.98
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. J Inherit Metab Dis (2015) 0.95
Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babies. J Med Screen (2011) 0.92
The consequences of extended newborn screening programmes: do we know who needs treatment? J Inherit Metab Dis (2008) 0.91
Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Pediatr (2004) 0.90
Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France. BMC Pediatr (2012) 0.88
Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet (2012) 0.87
Screening for lysosomal storage disorders--a clinical perspective. J Inherit Metab Dis (2006) 0.86
Newborn screening: new developments, new dilemmas. J Med Ethics (2005) 0.85
Organic acidurias: an updated review. Indian J Clin Biochem (2011) 0.85
Newborn screening in Canada - Are we out of step? Paediatr Child Health (2005) 0.83
Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis (2012) 0.82
Universal newborn hearing screening, a revolutionary diagnosis of deafness: real benefits and limitations. Eur Arch Otorhinolaryngol (2011) 0.81
Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis. Ont Health Technol Assess Ser (2003) 0.79
Population newborn screening for inherited metabolic disease: current UK perspectives. J Inherit Metab Dis (1999) 0.78
International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents. Eur J Hum Genet (2016) 0.78
Arguments for early screening: a clinician's perspective. Eur J Pediatr (2003) 0.77
Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry. BMJ (2002) 0.76
Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome. Eur J Pediatr (2003) 0.76
Newborn mass screening versus selective investigation: benefits and costs. J Inherit Metab Dis (2001) 0.75
Screening for medium chain acyl-CoA dehydrogenase deficiency is being evaluated. BMJ (2001) 0.75
The diagnosis of inherited metabolic diseases by microarray gene expression profiling. Orphanet J Rare Dis (2010) 0.75
Clinical characteristics of adult patients with inborn errors of metabolism in Spain: A review of 500 cases from university hospitals. Mol Genet Metab Rep (2017) 0.75
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Influence of delay on survival in patients with breast cancer: a systematic review. Lancet (1999) 13.10
Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet (1999) 5.58
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol (1972) 4.42
Prenatal origin of acute lymphoblastic leukaemia in children. Lancet (1999) 4.21
Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet (1992) 3.90
Evaluating computerized health information systems: hardware, software and human ware: experiences from the Northern Province, South Africa. J Public Health Med (1999) 3.80
Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care (1999) 3.62
Cumulative risk adjusted mortality chart for detecting changes in death rate: observational study of heart surgery. BMJ (1998) 3.62
Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet (1991) 3.60
Accelerating failure rate of the ASR total hip replacement. J Bone Joint Surg Br (2011) 3.47
Survey of scope of neonatal screening in the United Kingdom. BMJ (1995) 2.82
Breast feeding in Scotland. BMJ (1994) 2.49
Adverse reaction to metal debris following hip resurfacing: the influence of component type, orientation and volumetric wear. J Bone Joint Surg Br (2011) 2.47
Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screen (1994) 2.45
Perinatally related wastage--a proposed classification of primary obstetric factors. Br J Obstet Gynaecol (1986) 2.37
Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS (1992) 2.32
Clinical and chemical correlates in convulsions of the newborn. Lancet (1972) 2.25
Appraising clinical practice guidelines in England and Wales: the development of a methodologic framework and its application to policy. Jt Comm J Qual Improv (1999) 2.21
Immunoradiometric assay of parathyroid hormone. J Endocrinol (1971) 2.19
Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet (1990) 2.11
Relation between a career and family life for English hospital consultants: qualitative, semistructured interview study. BMJ (2000) 2.04
Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut (2003) 1.98
Enamel hypoplasia of the teeth associated with neonatal tetany: a manifestation of maternal vitamin-D deficiency. Lancet (1973) 1.93
The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase. Biochem J (1969) 1.76
D-2-hydroxyglutaric aciduria: case report and biochemical studies. J Inherit Metab Dis (1980) 1.69
Satisfaction with clinical nurse specialists in a breast care clinic: questionnaire survey. BMJ (1998) 1.66
Longitudinal study of thyroid function in Down's syndrome in the first two decades. Arch Dis Child (2005) 1.66
Determination of red-cell mass in assessment and management of anaemia in babies needing blood transfusion. Lancet (1986) 1.64
Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet (1991) 1.63
Maternal phenylketonuria: report from the United Kingdom Registry 1978-97. Arch Dis Child (2005) 1.62
Neurological aspects of perinatal asphyxia. Dev Med Child Neurol (1974) 1.61
Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis (1969) 1.59
Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis (1989) 1.56
Survival of human carrier erythrocytes in vivo. Clin Sci (Lond) (1999) 1.53
Neuroblastoma--when are urinary catecholamines and their metabolites 'normal'? Ann Clin Biochem (1988) 1.48
Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun Mass Spectrom (1999) 1.45
D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity? Ann Neurol (1999) 1.41
The NHS: assessing new technologies, NICE and value for money. Clin Med (2011) 1.40
What drives junior doctors to use clinical practice guidelines? A national cross-sectional survey of foundation doctors in England & Wales. BMC Med Educ (2015) 1.40
An evaluation of the prevalent round of the breast screening programme in south east Thames, 1988-1993: achievement of quality standards and population impact. J Med Screen (1996) 1.36
Renal function in diabetes mellitus. Arch Dis Child (1985) 1.34
Microscopic studies on skeletal muscle in gout patients treated with allopurinol. Q J Med (1971) 1.34
Appraising clinical guidelines: towards a "which" guide for purchasers. Qual Health Care (1994) 1.32
Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. Pediatr Res (1985) 1.31
Response of low birthweight infant to treatment with folic acid. Arch Dis Child (1971) 1.30
Neonatal convulsions associated with primary disturbance of calcium, phosphorus, and magnesium metabolism. Arch Dis Child (1973) 1.28
Hyaline-membrane disease, alkaline buffer treatment, and cerebral intraventricular halphaemorrhage. Lancet (1976) 1.28
Copper deficiency in the preterm infant of very low birthweight. Four cases and a reference range for plasma copper. Arch Dis Child (1985) 1.25
Sources of propionate in inborn errors of propionate metabolism. Metabolism (1990) 1.25
A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man. Clin Sci (1968) 1.25
Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res (1984) 1.22
Continuing education for medical professionals: a reflective model. Postgrad Med J (1997) 1.21
Free amino-acid concentrations in fetal fluids. Br Med J (1970) 1.19
Continuing medical education: the question of evaluation. Med Educ (1997) 1.19
Children intoxicated by alcohol in Nottingham and Glasgow, 1973-84. Br Med J (Clin Res Ed) (1986) 1.17
Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet (1989) 1.17
Radioimmunoassay and saturation analysis. The immunoradiometric assay and related techniques. Br Med Bull (1974) 1.17
"Nothing about me, without me": participatory action research with self-help/mutual aid organizations for psychiatric consumer/survivors. Am J Community Psychol (1998) 1.16
Robinow syndrome without mesomelic 'brachymelia': a report of five cases. J Med Genet (1986) 1.16
Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. J Inherit Metab Dis (2006) 1.16
Distribution of ions and electrical potential differences between mother and fetus in the human at term. J Obstet Gynaecol Br Commonw (1969) 1.16
The relationship between work history, work environment and low-back pain in men. Spine (Phila Pa 1976) (1984) 1.15
Routine referral for radiography of patients presenting with low back pain: is patients' outcome influenced by GPs' referral for plain radiography? Health Technol Assess (2000) 1.15
Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab (1998) 1.14
Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child (1995) 1.13
Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child (1983) 1.12
Prescribing exercise in general practice. Evaluation of scheme exists in Stockport. BMJ (1994) 1.11
What is core? Guidelines for the core curriculum in paediatrics. Med Educ (1997) 1.10
Microscopic studies on crystals in skeletal muscle from two cases of xanthinuria. J Pathol (1969) 1.10
Completing the feedback loop. BMJ (1991) 1.09
The quantitative extraction and gas-liquid chromatographic determination of organic acids in urine. Analyst (1972) 1.09
Continuing education for public health medicine--is it just another paper exercise? J Public Health Med (1996) 1.08
Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood (2001) 1.08
Neuropathology of biotinidase deficiency. Acta Neuropathol (1992) 1.08
Ribavirin aerosol for acute bronchiolitis. Arch Dis Child (1986) 1.07
Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol (1986) 1.05
Relationship of manual muscle testing to objective strength measurements. Muscle Nerve (1989) 1.05
Alcohol and the fetus in the west of Scotland. Br Med J (Clin Res Ed) (1983) 1.04
Ambulance economics. J Public Health Med (2000) 1.04
A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med (1998) 1.04
Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med (1999) 1.03
Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology (2008) 1.03
Treatment of thyrotoxicosis with lithium carbonate. Lancet (1974) 1.03
Dizygotic twins with 3-hydroxy-3-methylglutaric aciduria; unusual presentation, family studies and dietary management. Eur J Pediatr (1985) 1.03
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. Atherosclerosis (2003) 1.01
Biochemical and clinical studies of Friedreich's ataxia. J Neurol Neurosurg Psychiatry (1981) 1.01
Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur J Clin Invest (1979) 1.01
Relationship between urinary and serum growth hormone and pubertal status. Arch Dis Child (1992) 1.01
Membrane transport in resealed haemoglobin-containing human erythrocyte 'ghosts' prepared by a dialysis procedure. Biochem Biophys Res Commun (1979) 1.00
Urinary organic acids in man. I. Normal patterns. Clin Chem (1976) 0.99
Methaemoglobinaemia in children treated with prilocaine-lignocaine cream. BMJ (1990) 0.98
Changes in the urinary excretion of creatinine, albumin and N-acetyl-beta-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr (1996) 0.98